Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Latanoprost 0.005%, Xalatan®
Placebo
Locations
1
Austria
Department of Clinical Pharmacology
Vienna, Austria
Start Date
June 1, 2005
Primary Completion Date
September 1, 2009
Completion Date
January 1, 2010
Last Updated
June 11, 2018
NCT06689696
NCT07424417
NCT07152808
NCT06161012
NCT05713552
NCT05530889
Lead Sponsor
Medical University of Vienna
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions